Browse 349 uterine cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Endometrial cancer, which starts in the lining of the uterus, is the most common gynecologic cancer in the United States and one of the few cancers whose death rate has been rising. The most common early warning sign is bleeding after menopause, which is why it is often found early and treated with surgery. Research matters most for cancer that returns or has spread, where immunotherapy combined with chemotherapy became a standard first treatment only in the past few years, and trials are testing new targeted drugs matched to the tumor's genetic profile.
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
for
Endometrial Adenocarcinoma
Location: Boston MA, Providence RI, New York NY, Hackensack NJ,
Sponsor: Acrivon Therapeutics
Sex: Female
Age: 18+
Code: NCT05548296
Phase 2, Recruiting
Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire
for
Endometrial Cancer, Lynch Syndrome
Location: Vancouver
Sponsor: University of British Columbia
Sex: Female
Age: 30+
Code: NCT07194551
Recruiting
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
for
Endometrial Cancer
Location: St. John's, New Haven CT, Mineola NY, New York NY,
Sponsor: BioNTech SE
Sex: Female
Age: 18+
Code: NCT06340568
Phase 3, Recruiting
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
for
Malignant Female Reproductive System Neoplasm,
Location: Baltimore MD, Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03968406
Phase 1, Recruiting
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Jacksonville FL
Sponsor: Mayo Clinic
Sex: All
Age: 16+
Code: NCT05269381
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
for
Advanced Endometrial Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05039801
Phase 1, Recruiting
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
for
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05092373
Phase 1, Recruiting
Detecting HPV DNA in Anal and Cervical Cancers
for
Cervical Cancer, Anal Cancer,
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT04857528
Recruiting
Hypofractionated Radiochemotherapy
for
Uterine Cervix Cancer
Location: Lexington KY
Sponsor: Denise Fabian
Sex: Female
Age: 18 - 70+
Code: NCT06331468
Phase 2, Recruiting
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
for
Endometrial Clear Cell Adenocarcinoma,
Location: Maywood IL, Houston TX, Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 0+
Code: NCT03422198
Phase 3, Recruiting
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
for
Clinical Stage IV Gastric Cancer AJCC v8,
Location: Greenlawn NY, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT04329494
Phase 1, Recruiting
New
Developing and Implementing HPV SCREENED
for
Cervical Cancer Screening, Human Papilloma Virus
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: Female
Age: 30 - 65
Code: NCT07657104
Recruiting
New
A Community Based Intervention to Improve Cervical Cancer Screening Among Women in the Hispanic and East African Immigrant Community
for
Cervical Carcinoma
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: Female
Age: 30 - 65
Code: NCT07890402
Recruiting
New
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
for
Endometrial Neoplasms, Endometrial Cancer
Location: White Plains NY, Norfolk VA, Chesapeake VA, Suffolk VA,
Sponsor: Pfizer
Sex: Female
Age: 18+
Code: NCT07578649
Phase 3, Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors